Even though almost all U.S.-based cannabis businesses and lots of foreign American Depository Receipts (ADRs) trade within the countertop (OTC), a couple of cannabis businesses are traded from the NASDAQ. Some investors prefer shares which are listed on the NASDAQ with other exchanges for their increased liquidity and tighter spreads set alongside the markets that are over-the-counter. For instance, since the cannabis industry is continuing to grow in recent months and years, uplisting from an OTC market to a professional U.S. change is becoming a banner achievement for a lot of increasing marijuana businesses. (For associated reading, see “Understanding healthcare Cannabis vs. Recreational Cannabis Stocks”)
An number that is increasing of organizations are now being noted on reputable U.S. exchanges in place of being exchanged regarding the OTC market showing the quick development of the cannabis industry.
NASDAQ-listed Marijuana Stocks
The NASDAQ had been the initial electronic change and is definitely similar to technology and biotechnology. The cannabis organizations from the NASDAQ mirror this, therefore the greater part of them run into the biotech area of this industry. Here you will find the NASDAQ-listed cannabis shares, in alphabetical order, at the time of October 26, 2019, with a failure of the total returns.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
Arena Pharmaceuticals is really a biotech business active in the production of medical marijuana medications. Research and development around Arena’s APD371 could be the focus that is primary of firm’s cannabis biotech initiatives.
Atlantic Alliance Partnership Corp. (NASDAQ:AAPC)
Atlantic Alliance Partnership Corp. is a blank check business that is currently in a merger contract with Kalyx developing Inc. Kalyx is a respected investment rely upon the regulated cannabis industry in the us.
- The cannabis industry, specially the section of cannabis and biotech, is attracting substantial investor attention.
- Cannabis has been found in brand new medications to treat discomfort and numerous chronic, inflammatory, and fibrotic conditions.
- Businesses will also be developing cannabinoid items for autism range problems, schizophrenia, glioma, Tourette problem, epileptic problems, Prader-Willi Syndrome (a hereditary disorder), and addiction that is amphetamine.
Cara Therapeutics Inc. (NASDAQ:CARA)
Cara Therapeutics is really a clinical-stage biotechnology business focused on developing and commercializing new chemical entities when it comes to indications of discomfort and pruritus (itching). Although every one of the company’s clinical-stage items target opioid receptors, Cara happens to be performing preclinical research on cannabinoids for the treatment of neuropathic discomfort.
Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)
Corbus Pharmaceuticals Holdings Inc. is a cannabis biotech business. The team’s research, development, and production are based around cannabis medications that look for to deal with chronic, inflammatory, fibrotic, along with other conditions.
Cronos Group Inc. (NASDAQ:CRON)
Cronos Group Inc. is just a cannabis that are canadian. The team has and seeks cannabis-related subsidiaries and licensed manufacturers. In December of 2018, Marlboro manufacturer Altria announced intends to spend $1.8 billion in Cronos. The investment has provided Cronos not just with extra money to invest in its continued expansion but in addition with a partner that is well-established within the advertising of customer brands.
Greenlane Holdings Inc. (NASDAQ:GNLN)
Greenlane Holdings Inc. is really a Boca Raton, Florida-based cannabis business. It distributes many different cannabis consumption add-ons and vaporization gear and items to customers that are retail the U.S. and Canada. Furthermore, it runs websites that are e-commerce extra product sales.
GW Pharmaceuticals Plc. (NASDAQ:GWPH)
GW Pharmaceuticals is creating a profile of cannabinoid medications. These medications consist of Sativex for the treating spasticity associated with sclerosis that is multiple cancer tumors pain and Epidiolex to treat youth epilepsy. Sativex is commercialized much more compared to a dozen nations away from united states of america and contains gotten approval that is regulatory some other nations. Epidiolex received Food And Drug Administration approval as a treatment for Dravet Syndrome and Lennox-Gastaut Syndrome, two types of serious, very early beginning epilepsy without good existing treatment plans. Other indications reveal that GW Pharmaceuticals is developing products that are cannabinoid autism range problems, schizophrenia, and glioma.
Intec Pharma Ltd. (NASDAQ:NTEC)
Intec Pharma is a clinical-stage biopharmaceutical business that is developing medications centered on its proprietary Accordion Pill technology. Intec’s item pipeline includes cannabinoid-based drugs for lower pain that is back fibromyalgia.
Marrone Bio Innovations, Inc. (NASDAQ:MBII)
Marrone Bio Innovations, Inc. develops and distributes environmentally responsible bio-based pest administration and plant wellness items. In 2017, Marrone Bio Innovations announced that three MBII ingredients that are active now appropriate for usage on cannabis crops within the California cultivation market.
Modern Beverages Corp. (NASDAQ:NBEV)
Modern age Beverages Corp. is a maker of beverages based on yerba mate, green tea extract, kombucha, and similar products. In present months, modern age has expanded its beverage offerings to incorporate CBD infusions aswell, bringing it to the orbit of cannabis shares.
OrganiGram Holdings Inc. (NASDAQ:OGI)
Canadian cannabis producer OrganiGram Holdings Inc. debuted regarding the NASDAQ in might of 2019, rendering it the most current cannabis businesses to record in the exchange that is popular. The organization was quickly expanding its manufacturing capability and might manage to produce up to 113,000 kilograms of product per 12 months because of the end of 2019.
Psychemedics Corporation (NASDAQ:PMD)
Psychemedics Corporation runs when you look at the enforcement sector. The business’s business operations support medication evaluation through hair examples.
Sundial Growers Inc. (NASDAQ:SNDL)
Alberta, Canada-based Sundial Growers Inc. is yet another brand new entry on the NASDAQ change. The cannabis producer made headlines in October of 2019 (and saw a price that is brief) whenever it announced the production of a brand new Palmetto model of leisure cannabis, first for sale in Saskatchewan and Manitoba.
Therapix Biosciences Ltd. (NASDAQ:TRPX)
Therapix Biosciences Ltd. is a specialty clinical-stage company that is pharmaceutical in the development of cannabinoid-based drugs. Therapix’s present pipeline includes items targeted to treat Tourette syndrome and mild intellectual disability.
Tilray Inc. (NASDAQ:TLRY)
Tilray Inc. had been the very first marijuana-related company to have a preliminary general public providing (IPO) in the usa. The Nanaimo, Vancouver company that is island-based on medical cannabis products.
Village Farms Global (NASDAQ:VFF)
Village Farms Global is one of cannabis that are recent to begin exchanging on the NASDAQ. The business’s stocks became readily available for trade on February 21 cannabis oil, 2019. The business includes a history that is decades-long greenhouse produce production and has now just recently shifted some of its focus toward cannabis manufacturing.
Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE)
Zynerba Pharmaceuticals is targeted regarding the development of synthetic cannabinoid remedies for transdermal (through your skin) distribution. Their pipeline presently includes two medications being developed for indications epilepsy that is including osteoarthritis, fibromyalgia, peripheral neuropathic discomfort, and delicate X syndrome.